answersLogoWhite

0

✔The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) . The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S.

✔CDC has received increased reports of myocarditis and pericarditis in adolescents and young adults after COVID-19 vaccination.

✔The known and potential benefits of COVID-19 vaccination outweigh the known and potential risks, including the possible risk of myocarditis or pericarditis.

What else can I help you with?